Creative Medical Technology Holdings Inc (CELZ)

[monte379]

This is what the INVESTORS KNOW about CMTH.......but don't trust me or anyone on the blog. Do you own DD please, and you too will KNOW......

The FDA does not regulate medical procedures performed by qualified and licensed doctors. CaverStem has the only clinically proven procedure to treat Erectile Dysfunction with adult stem cells in the US. CaverStem ONLY uses your own adult stem cells (not Embryonic stem cells) and they are not altered, manipulated or stored. Therefore, FDA does not object to these procedures.

CaverStem has been shown to be effective even in patients who do not respond to PDE5 inhibitors. CaverStem is safe.

Several doctors in the US have been vetted and signed and are now OPEN and treating patients (Doctors Gershman, Said, Bieri, Liu, Narayan, Niemczyk and Sanderson). Currently you can make an appointment any of those locations.

Dr. Antonini from Italy has also began treating patients in 2019 and we know patients were treated in Russia. CELZ reported that three more doctors are scheduled for training in March and April.

Over 50 domain names have been registered showing that MANY more doctors are being vetted or have shown interest. These includes MANY cities and states in the USA, and now we KNOW there are domains registered in Russia (PromoMed, Dr. Pushkar), Germany, France, Switzerland (Alto Uro, Dr. Bachmann) and Austria.

CaverStem has begun a series of mailer and email campaigns introducing the CaverStem procedure to licensed physicians in the areas of urology, sexual function and plastic surgery. This campaign which will be expanded on a monthly basis with follow up mailers and emails and calls from our sales representatives. It's the goal to reach out to a minimum of 2500 new physicians each month by these methods. CaverStem reported good replies from the January emails.

CaverStem has also increased its online presence on Social Media and by placing banner advertising on websites and search engines attracting the active male. They are currently scripting an advertising campaign in Los Angeles and will be the first city to expand into print and TV.

U.S. and international agreements have been reached for exclusive distribution rights for the FDA approved Generation 2 bone marrow harvest technology which has been used with multiple ED patients with excellent results.

Your DD will show that Dr. Gershman has been performing the procedure with EXCELLENT results…90% success rate, even in difficult patients.

A one-year trial has concluded and will PROVE the same results and you can watch it here; https://clinicaltrials.gov/ct2/show/NCT03699943?recrs=deghi&fund=2&lupd_s=09%2F27%2F2018&lupd_d=14 Please review this. You will be surprised by the patients ages IMO.

Revenue has now started, CMTH is cash flowing. Additional physicians are scheduled for training, patients are being treated and revenues are being generated and increasing each month. CMTH anticipates reaching financial self-sufficiency by revenues from sales in 2019.

CMTH has Institutional Investors now, slowing dilution and providing much better terms as CMTH completes the commercialization phase. The most recent notes that were issued in 2018 were renegotiated providing cash for operations.

CaverStem signed with PatientGain to redesigning the website for the anticipated HUGE volume of traffic CaverStem will generate. This has generated many calls to the vetted doctors.

CMTH has started commercializing and scheduling patients for the FemCelz procedure for the treatment of female sexual dysfunction using stem cells from the patient's own bone marrow. Many of the existing CaverStem affiliated physician's will also treat female patients for sexual function and we anticipate that they will be the leaders in progressing the FemCelz program.

CMTH anticipates acquiring the Virility Centers of America brand from affiliate company Creative Medical Health, Inc. in Q1 2019. The use of the Virility Centers brand is related to male and female wellness clinics, including sexual function (CaverStemTM and FemCelzTM), incontinence and infertility. This brand will compliment the CaverStem and FemCelz brands.

CaverStem and FemCelz are just TWO of SEVERAL patents held by CMTH. 4 NEW patents were applied for in 2018.

Gershman and Ichim have already successfully commercialized Medistem.

CaverStem, FemCelz, StemSpine & AmnioStem have all be TRADEMARKED

We KNOW CaverStem + StemSpine + AmnioStem = NASDAQ

PLEASE read the sticky posts seen when logging in to iHub through a browser!!